JPS61286330A - 経口徐放性製剤 - Google Patents

経口徐放性製剤

Info

Publication number
JPS61286330A
JPS61286330A JP12513985A JP12513985A JPS61286330A JP S61286330 A JPS61286330 A JP S61286330A JP 12513985 A JP12513985 A JP 12513985A JP 12513985 A JP12513985 A JP 12513985A JP S61286330 A JPS61286330 A JP S61286330A
Authority
JP
Japan
Prior art keywords
drug
polyacrylic acid
lower alkyl
alkyl ether
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12513985A
Other languages
English (en)
Japanese (ja)
Other versions
JPH057367B2 (en:Method
Inventor
Hiroshi Igura
井倉　宏
Yoshiki Suzuki
嘉樹 鈴木
Tsuneji Nagai
永井　恒司
Ryoji Machida
良治 町田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP12513985A priority Critical patent/JPS61286330A/ja
Priority to EP86304400A priority patent/EP0205336B1/en
Priority to DE8686304400T priority patent/DE3681348D1/de
Priority to US06/872,996 priority patent/US4777033A/en
Publication of JPS61286330A publication Critical patent/JPS61286330A/ja
Priority to MYPI87001165A priority patent/MY102459A/en
Publication of JPH057367B2 publication Critical patent/JPH057367B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
JP12513985A 1985-06-11 1985-06-11 経口徐放性製剤 Granted JPS61286330A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP12513985A JPS61286330A (ja) 1985-06-11 1985-06-11 経口徐放性製剤
EP86304400A EP0205336B1 (en) 1985-06-11 1986-06-10 Oral sustained release pharmaceutical preparation
DE8686304400T DE3681348D1 (de) 1985-06-11 1986-06-10 Oral-arzneizubereitung mit retardwirkung.
US06/872,996 US4777033A (en) 1985-06-11 1986-06-11 Oral sustained release pharmaceutical preparation
MYPI87001165A MY102459A (en) 1985-06-11 1987-07-29 Oral sustained release pharmaceutical preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12513985A JPS61286330A (ja) 1985-06-11 1985-06-11 経口徐放性製剤

Publications (2)

Publication Number Publication Date
JPS61286330A true JPS61286330A (ja) 1986-12-16
JPH057367B2 JPH057367B2 (en:Method) 1993-01-28

Family

ID=14902826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12513985A Granted JPS61286330A (ja) 1985-06-11 1985-06-11 経口徐放性製剤

Country Status (1)

Country Link
JP (1) JPS61286330A (en:Method)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6277335A (ja) * 1985-09-30 1987-04-09 Fujisawa Pharmaceut Co Ltd ゲル層形成型徐放性製剤
JPS63227519A (ja) * 1987-02-27 1988-09-21 イーライ・リリー・アンド・カンパニー 徐放性マトリックス製剤
US5174998A (en) * 1988-11-30 1992-12-29 Nisshin Flour Milling Co., Ltd. Sustained release compositions using as matrix hemicellulose extracted from wheat bran
JP2003531849A (ja) * 2000-04-28 2003-10-28 アダムス ラボラトリーズ，インコーポレーテッド グアイフェネシン徐放製剤および錠剤
JP2013504615A (ja) * 2009-09-23 2013-02-07 コリア ユナイテッド ファーム，インク 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
JP2013224273A (ja) * 2012-04-20 2013-10-31 Nisshin Pharma Inc 腸内環境改善有核錠製剤及びハードカプセル製剤
JP2015042669A (ja) * 2014-10-30 2015-03-05 コリア ユナイテッド ファーム，インク 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
WO2024058093A1 (ja) * 2022-09-16 2024-03-21 東和薬品株式会社 時限放出型顆粒およびその用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60185728A (ja) * 1983-12-01 1985-09-21 ハンス　ロウエイ 徐放性医薬担体
JPS61148115A (ja) * 1984-12-21 1986-07-05 Tooa Eiyoo Kk 難溶性薬物の徐放性製剤及びその製造法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60185728A (ja) * 1983-12-01 1985-09-21 ハンス　ロウエイ 徐放性医薬担体
JPS61148115A (ja) * 1984-12-21 1986-07-05 Tooa Eiyoo Kk 難溶性薬物の徐放性製剤及びその製造法

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6277335A (ja) * 1985-09-30 1987-04-09 Fujisawa Pharmaceut Co Ltd ゲル層形成型徐放性製剤
JPS63227519A (ja) * 1987-02-27 1988-09-21 イーライ・リリー・アンド・カンパニー 徐放性マトリックス製剤
US5174998A (en) * 1988-11-30 1992-12-29 Nisshin Flour Milling Co., Ltd. Sustained release compositions using as matrix hemicellulose extracted from wheat bran
JP2003531849A (ja) * 2000-04-28 2003-10-28 アダムス ラボラトリーズ，インコーポレーテッド グアイフェネシン徐放製剤および錠剤
JP2013504615A (ja) * 2009-09-23 2013-02-07 コリア ユナイテッド ファーム，インク 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
JP2013224273A (ja) * 2012-04-20 2013-10-31 Nisshin Pharma Inc 腸内環境改善有核錠製剤及びハードカプセル製剤
JP2015042669A (ja) * 2014-10-30 2015-03-05 コリア ユナイテッド ファーム，インク 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
WO2024058093A1 (ja) * 2022-09-16 2024-03-21 東和薬品株式会社 時限放出型顆粒およびその用途

Also Published As

Publication number Publication date
JPH057367B2 (en:Method) 1993-01-28

Similar Documents

Publication Publication Date Title
US4777033A (en) Oral sustained release pharmaceutical preparation
ES2295062T3 (es) Formulacion granulada de liberacion sostenida.
JP3806740B2 (ja) 薬剤運搬組成物
JP3251190B2 (ja) 体液と接触することにより容積が高度に増加する薬学的圧縮錠剤
US8460706B2 (en) Hydrophilic/lipophilic polymeric matrix dosage formulation
JP2916153B2 (ja) 徐放性製剤
CN102325526B (zh) 延长释放的药物制剂
KR880002673B1 (ko) 진통 캡슐제와 그 제조방법
EP0941075B1 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
JP2002533380A (ja) 多孔性粒子を含む剤形
TW200301139A (en) Zero-order sustained release dosage forms and method of making same
WO1997047285A1 (en) Gastric-retentive oral controlled drug delivery system with enhanced retention properties
CN112805241A (zh) 多孔二氧化硅颗粒组合物
JP2005506323A (ja) 経口送達用機能性散剤
CN101961317A (zh) 受控制的凝聚
TW200539902A (en) Oral pharmaceutical compositions of timed-release particles and tablets quickly disintegrable in the oral cavity containing compositions thereof
JPH04290816A (ja) 延長された胃の滞留時間を有する制酸調製物
WO2006082523A2 (en) Pharmaceutical sustained release composition of metformin
WO2002024203A2 (en) Controlled release formulations for oral administration
JP2006507216A (ja) 用量ダンピングの恐れを低減させた新規な薬物送達システムとしての徐放性固形製剤
ES2702608T3 (es) Formulación de dosificación farmacéutica con matriz de liberación controlada
JPS61286330A (ja) 経口徐放性製剤
CA2543454A1 (en) Drug-containing coated microparticles for quick-disintegrating oral tablets
JP6905972B2 (ja) 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
JP6924177B2 (ja) 医薬組成物粒子とそれを含む口腔内崩壊製剤

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees